The development of preimplantation genetic diagnosis for myotonic dystrophy
using multiplex fluorescent polymerase chain reaction and its clinical application.
Groh, "Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy
type I," American Heart Journal, vol.
is a very complex molecular pathology, with multisystemic involvement [2-9].
Molecular Genetics and Genetic Testing in Myotonic Dystrophy
* The report reviews pipeline therapeutics for Myotonic Dystrophy
by companies and universities/research institutes based on information derived from company and industry-specific sources
Natural history of skeletal muscle involvement in myotonic dystrophy
type 1: A retrospective study in 204 cases.
In general, dysphagia appeared to be a symptom that participants felt the individual with myotonic dystrophy
had compensated for and managed; therefore, swallowing dysfunction did not seem to cause great concern or to affect shared experiences like mealtimes or social activities.
is the commonest adult neuromuscular disorder, but affected individuals may also present with cataracts, cardiac conduction defects or neonatal hypotonia.
This report provides comprehensive information on the therapeutic development for Myotonic Dystrophy
, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
(6.) Chiaramonti A, Gilgor RS: Pilomatricomas associated with myotonic dystrophy
. Arch Dermatol 1978; 114:1363.
type 2 is a relatively rare form of muscular dystrophy that is somewhat milder than myotonic dystrophy
type 1, the most common adult-onset form of the disease.
(DM) is a common neuromuscular disorder comprising at least two genetically different forms.